Entering text into the input field will update the search result below

Atea rejects takeover offer from Tang Capital Partners

May 30, 2023 9:11 AM ETAtea Pharmaceuticals, Inc. (AVIR)By: Dulan Lokuwithana, SA News Editor
acquisitions stands on the desk against the background of books stacked, calculator, pen, green potted plant.


  • Atea Pharmaceuticals (NASDAQ:AVIR), a company focused on oral antivirals, added ~3% pre-market Tuesday after announcing that its board of directors unanimously rejected an unsolicited takeover offer from Tang Capital Partners, LP.
  • Following a review with independent financial and legal advisors, the board has

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About AVIR

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
Atea Pharmaceuticals, Inc.
Xeris Biopharma Holdings, Inc.
Nuvation Bio Inc.
Terns Pharmaceuticals, Inc.
EyePoint Pharmaceuticals, Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.